Meropenem (CAS 96036-03-2) is a high-potency antibacterial API with a broad spectrum of activity, specifically designed to combat severe bacterial infections. As a carbapenem antibiotic, it exhibits strong bactericidal effects by inhibiting bacterial cell wall synthesis, making it effective against both gram-positive and gram-negative bacteria, including multi-drug resistant strains.
Its exceptional purity and stable molecular structure ensure reliable therapeutic efficacy, meeting strict pharmaceutical standards for bulk drug production. Suitable for formulating injectable medications, it is widely used in clinical settings to treat infections of the respiratory tract, urinary tract, abdomen, skin, and soft tissues, as well as sepsis and other life-threatening conditions.
For pharmaceutical manufacturers and research institutions seeking a trusted antibacterial ingredient, this product offers unparalleled effectiveness, consistent quality, and cost-efficiency. It eliminates the risk of substandard raw materials, supporting the development of safe and potent antibacterial drugs that address unmet medical needs.
